文献速递食管与纵隔外科

单孔机器人手术治疗纵隔肿瘤23例初步结果

Initial Outcome of Single-port Robotic Surgery for Mediastinal Tumours with 23 Cases.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

本研究回顾性分析了23例自2024年2月起接受da Vinci SP单孔机器人辅助纵隔肿瘤切除术的患者,经剑突下或肋下入路。主要终点为中转开胸/胸骨或增加孔的发生率(可行性)及Clavien-Dindo≥IIIa级30天并发症发生率(安全性)。结果显示中转率0%(0/23),严重并发症率0%(0/23),所有患者均实现R0切除,中位手术时间128分钟,中位住院5天,提示该技术安全可行且短期效果良好。

要点

  • da Vinci SP单孔机器人纵隔肿瘤切除术中转率0%(0/23),严重并发症率0%(0/23)。
  • 所有患者均实现R0切除,中位手术时间128分钟,中位住院5天。
  • 短期结果良好,但需更多病例及与多孔机器人、VATS和开放手术的对比研究。

核心结论

  • 23例初步经验表明da Vinci SP单孔机器人纵隔肿瘤切除术安全可行,短期术后结果良好。

研究设计与样本

  • 回顾性分析23例自2024年2月起在本机构接受da Vinci SP机器人辅助纵隔肿瘤切除术的患者,采用剑突下或肋下入路。
  • 主要终点为中转开胸/胸骨或增加孔的发生率(可行性)及Clavien-Dindo≥IIIa级30天并发症发生率(安全性)。

主要发现

  • 中位手术时间128分钟,中位控制台时间96分钟。
  • 中位出血量10 g,中位引流时间1天,中位住院时间5天。
  • 中转率0%(0/23),严重并发症率0%(0/23),所有患者均实现R0切除。

临床怎么用

  • 对于纵隔肿瘤,da Vinci SP单孔机器人手术可作为安全可行的微创选择,短期效果良好。

局限性

  • 需进一步积累病例并与传统多孔机器人系统、电视辅助胸腔镜手术(VATS)和开放手术进行对比研究,以评估长期疗效和患者预后。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This study aimed to report the safety, feasibility, initial outcomes, and utility of the da Vinci SP (single-port) robotic system for mediastinal tumour resection. The primary end-points were defined as the rate of conversion to thoracotomy/sternotomy or additional ports (feasibility), and the incidence of 30-day postoperative complications classified as Clavien-Dindo grade ≥IIIa (safety). METHODS: We retrospectively analysed data from 23 patients who underwent da Vinci SP robot-assisted mediastinal tumour resection via the subxiphoid or subcostal approaches at our institution since February 2024. The primary end-points (conversion rate and severe complication rate) and key perioperative outcomes, including surgical time, console time, blood loss, drainage duration, and length of hospital stay, were assessed. RESULTS: The median operative time was 128 min and the median console time was 96 min. The median blood loss was 10 g, with a median drainage period of 1 day and a median hospital stay of 5 days. The conversion rate was 0% (0/23 cases), and the severe complication rate was 0% (0/23 cases). All patients underwent R0 resection. CONCLUSIONS: Our initial experience with 23 cases suggests that the da Vinci SP single-port robotic system for mediastinal tumour resection is safe and feasible, with favourable short-term postoperative outcomes. Further accumulation of cases and comparative studies with conventional multiport robotic systems, video-assisted thoracoscopic surgery (VATS), and open surgery are warranted to assess the long-term efficacy and patient prognoses. CLINICAL REGISTRATION NUMBER: H2025-092 (Observational study to verify the results of robotic surgery in thoracic surgery).

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Ito D, Kaneda S, Kawaguchi T, et al. Initial Outcome of Single-port Robotic Surgery for Mediastinal Tumours with 23 Cases. Eur J Cardiothorac Surg. 2026. PMID: 41390913. doi:10.1093/ejcts/ezaf443

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。